Prokidney (PROK) Operating Leases (2021 - 2026)
Prokidney's (PROK) quarterly Operating Leases came in at $2.4 million in Q2 2026, down 31.89% year-over-year from $3.5 million in Q2 2025, and down 10.5% quarter-over-quarter from $2.7 million in Q1 2026.
Analysis
Prokidney (PROK) Operating Leases (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Operating Leases for 6 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Leases fell 31.89% year-over-year to $2.4 million in Q2 2026; TTM through Jun 2026 was $2.4 million, a 31.89% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, up 19.99% from the prior year.
- Operating Leases was $2.4 million for Q2 2026 at Prokidney, down from $2.7 million in the prior quarter.
- Over five years, Operating Leases peaked at $5.6 million in Q2 2024 and troughed at $1.7 million in Q3 2022.
- A 5-year average of $3.1 million and a median of $2.6 million in 2025 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases jumped 154.72% in 2024 and slumped 48.3% in 2025, its largest moves.
- Over 5 years, Operating Leases stood at $1.9 million in 2022, then jumped by 89.4% to $3.6 million in 2023, then tumbled by 31.55% to $2.5 million in 2024, then rose by 19.99% to $3.0 million in 2025, then retreated by 19.26% to $2.4 million in 2026.
- The last three Operating Leases figures came in at $2.4 million (Q2 2026), $2.7 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 5.37 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 3.61 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.47 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Dec 31, 2021 | 1.07 Mn |